Rise in number of chronic and lifestyle disorders, which lead to various cancer such as breast cancer is the major factor that contributes to the growth of the women’s health diagnostics market. Moreover, rise in diabetic population, increase in geriatric population, and introduction of novel drugs to control symptoms such as nausea and vomiting fuel the market growth. However, side effects related to gastroparesis drugs, time-consuming regulatory process for the approval of drugs, and complications in gastroparesis diagnosis hamper the growth of the market. Conversely, surge in demand for the development of user-friendly drugs, rise in healthcare infrastructure, and creative marketing initiatives by key vendors in emerging countries are expected to provide lucrative opportunities for the market expansion during the forecast period. The global women’s health diagnostics market is segmented on the basis of type, end user, and region. By type, it is classified into diagnostic devices, diagnostic tests, and accessories and consumables. The diagnostic devices segment is further segmented into biopsy devices and imaging and monitoring system. Imaging and monitoring systems segment is further segmented into ultrasound imaging systems, mammography systems, MRI systems, and nuclear imaging. Ultrasound imaging systems is further sub segmented into OB/GYN ultrasound and breast ultrasound. Mammography systems are further categorized as analog mammography systems, digital mammography systems, and breast tomosynthesis system. Diagnostic tests segment is further categorized as breast cancer testing, cervical cancer testing, prenatal genetic screening and carrier testing, pregnancy and ovulation testing, and ovarian cancer testing. Breast cancer testing is further segmented into hormone receptor test, immunohistochemistry test, and other tests. Cervical cancer testing is bifurcated into PAP smear and HPV test. Prenatal genetic screening and carrier testing includes tests for cystic fibrosis and other diseases. The pregnancy and ovulation testing segment is further bifurcated into lab-based pregnancy and ovulation testing, and home-based pregnancy and ovulation testing. Depending on end user, it is categorized into hospitals and clinics, home care settings, diagnostic and imaging centers, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA. KEY BENEFITS FOR STAKEHOLDERS The study provides an in-depth analysis of the global women’s health diagnostics market with current trends and future estimations from 2016 to 2023 to elucidate the imminent investment pockets. Comprehensive analysis of factors that drive and restrict the market growth is provided. Identification of factors instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global & regional scale are provided. Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market. KEY MARKET SEGMENTS By Type Diagnostic Devices Biopsy Devices Imaging and Monitoring System Ultrasound Devices OB/GYN Ultrasound Breast Ultrasound Mammography Systems Analog Mammography Digital Mammography Breast Tomosynthesis MRI Systems Nuclear Imaging Diagnostic Tests Breast Cancer Testing Hormone Receptor Test Immunohistochemistry (IHC) Test Other Tests Cervical Cancer Testing PAP Smear (PAP) Test HPV Test Prenatal Genetic Screening and Carrier Testing Cystic Fibrosis Other Diseases Pregnancy and Ovulation Testing Lab-based Pregnancy and Ovulation Testing Home Based Pregnancy and Ovulation Testing Ovarian Cancer Testing Accessories and Consumables By End User Hospitals and Clinics Home Care Settings Diagnostic and Imaging Centers Others By Region North America U.S. Canada Mexico Europe Germany France UK Italy Spain Rest of Europe Asia-Pacific Japan China Australia India South Korea Rest of Asia-Pacific LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA LIST OF KEY PLAYERS PROFILED IN THE REPORT Abbott Laboratories Becton, Dickinson and Company Carestream Health F. Hoffmann-La Roche AG GE Healthcare Hologic, Inc. Koninklijke Philips N.V. Quest Diagnostics Inc. Siemens AG Cardinal Health LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request) Cook Medical Incorporated C. R. Bard, Inc. MedGyn Products, Inc. Thermo Fisher Scientific
What is the estimated value of the Global Women’S Health Diagnostics Market?
What is the growth rate of the Global Women’S Health Diagnostics Market?
What is the forecasted size of the Global Women’S Health Diagnostics Market?
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.